Abstract
Recombinant single-chain Fv antibody fragments (scFv) can be combined with liposomes to generate immunoliposomes for targeted drug delivery. Recent studies have shown that scFv molecules modified to express a C-terminal cysteine residue can be used for site-directed chemical conjugation. Here, we present a new method by immobilizing scFv fragments via their C-terminal hexahistidyl-tag on liposomes containing Ni-NTA-lipids (Ni-NTA-DOGS) in their lipid bilayer without the need to introduce additional reactive groups in the protein. Using an anti-endoglin scFv as a model antibody, we could show that scFv molecules are efficiently immobilized on the liposome surface and that these immunoliposomes bind specifically and strongly to endoglin-expressing endothelial cells. This approach allows for a rapid and flexible generation of target cell-specific immunoliposomes.
MeSH terms
-
Drug Delivery Systems
-
Humans
-
Immunoglobulin Fragments / administration & dosage*
-
Immunoglobulin Fragments / chemistry
-
Immunoglobulin Fragments / metabolism
-
Immunoglobulin Variable Region / administration & dosage*
-
Immunoglobulin Variable Region / chemistry
-
Immunoglobulin Variable Region / metabolism
-
In Vitro Techniques
-
Liposomes
-
Nitrilotriacetic Acid / analogs & derivatives*
-
Nitrilotriacetic Acid / chemistry
-
Organometallic Compounds / chemistry*
-
Particle Size
-
Protein Binding
-
Recombinant Proteins / administration & dosage
-
Recombinant Proteins / chemistry
-
Recombinant Proteins / metabolism
-
Triglycerides / chemistry*
Substances
-
Immunoglobulin Fragments
-
Immunoglobulin Variable Region
-
Liposomes
-
Organometallic Compounds
-
Recombinant Proteins
-
Triglycerides
-
immunoglobulin Fv
-
1,2-dioleoyl-3-succinylglycerol
-
nickel nitrilotriacetic acid
-
Nitrilotriacetic Acid